Abnormal Autonomic Nervous Control of the Cardiovascular System

  • Giuseppe M. C. Rosano
  • Gabriele Fragasso
  • Sergio L. Chierchia
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 213)


The pathogenetic mechanisms underlying chest pain in patients with angina and normal coronary arteriograms are controversial and there is no consensus regarding the cause of symptoms in these patients. The identification of a pathogenetic mechanism for syndrome X is complicated by the heterogeneity of patients encompassed by this syndrome. In fact, syndrome X is a true syndrome and not a disease. As such it is based on clinical features such as chest pain and normal coronary arteriograms. These may be the expression of various, often unrelated, disorders.


Heart Rate Variability Sympathetic Activity Coronary Flow Reserve Coronary Blood Flow Autonomic Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mammohansingh P, Parker JO: Angina pectoris with normal coronary arteriograms: hemodynamic and metabolic response to atrial pacing. Am Heart J 1975;90:555–561.PubMedCrossRefGoogle Scholar
  2. 2.
    Kaski JC, Crea F, Nihoyannopoulos P, Hackett D, Maseri A: Transient myocardial ischemia during daily life in patients with syndrome X. Am J Cardiol 1986;58:1242–1247.PubMedCrossRefGoogle Scholar
  3. 3.
    Montorsi P, Manfredi M, Loaldi A, Fabbiocchi F, Polese A, de Cesare N, Bartorelli A, Guazzi MD: Comparison of coronary vasomotor responses to nifedipine in syndrome X and in Prinzmetal’s angina pectoris. Am J Cardiol 1989;63:1198–1202.PubMedCrossRefGoogle Scholar
  4. 4.
    Ishihara T, Seki I, Yamada Y, Tamoto S, Fukai M, Takada K, Fujiwara M, Ashida H, Shimada T, Ohsawa N: Coronary circulation, myocardial metabolism and cardiac catecholamine flux in patients with syndrome X. J Cardiol 1990;20:267–274..PubMedGoogle Scholar
  5. 5.
    Camici PG, Marraccini P, Lorenzoni R, Buzzigoli G, Pecori N, Perissinotto A, Ferrannini E, L’Abbate A, Marzilli M: Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. J Am Coll Cardiol 1991;17:1461–1470.PubMedCrossRefGoogle Scholar
  6. 6.
    Romeo F, Gaspardone A, Ciavolella M, Gioffrè P, Reale A: Verapamil versus acebutolol for syndrome X. Am J Cardiol 1988;62:312–313.PubMedCrossRefGoogle Scholar
  7. 7.
    Rosano GMC, Kaski JC, Maseri A, Poole-Wilson PA: Early increase of blood pressure during exercise in patients with syndrome X predicts the development of systemic hypertension. Eur Heart J 1992;13:87Google Scholar
  8. 8.
    Galassi AR, Kaski JC, Crea F, Pupita G, Gavrielides S, Tousoullis D, Maseri A: Heart rate response during exercise testing and ambulatory ECG monitoring in patients with syndrome X. Am Heart J 1991;122:458–463.PubMedCrossRefGoogle Scholar
  9. 9.
    Galassi AR, Kaski JC, Pupita G, Vejar M, Crea F, Maseri A: Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X. Am J Cardiol 1989;64:264–269.Google Scholar
  10. 10.
    Camici PG: Studies of coronary blood flow and myocardial metabolism in patients with chest pain and angiographically normal coronary arteries, in Kaski JC (ed): Angina pectoris with normal coronary arteries: syndrome X. London, Kluwer Academic Publishers, 1994, pp 149–164.CrossRefGoogle Scholar
  11. 11.
    Borghi A, Di Clemente D, Puddu GM, Ruggeri A, Bugiardini R: Long-term clinical outcome of patients with angina pectoris, normal coronary angiograms and evidence of myocardial ischemia. J Am Coll Cardiol 1993;21:476A.Google Scholar
  12. 12.
    Buffington CW, Feigl EO: Adrenergic coronary vasoconstriction in the presence of coronary stenosis in the dog. Circ Res 1981;48:416–423.PubMedCrossRefGoogle Scholar
  13. 13.
    Heusch G, Deussen A: The effects of cardiac sympathetic nerve stimulation on the perfusion of stenotic coronary arteries in dog. Circ Res 1983;53:8–15.PubMedCrossRefGoogle Scholar
  14. 14.
    Nathan HJ, Feigl EO: Adrenergic vasoconstriction lessen transmural steal during coronary hypoperfusion. Am J Physiol 1986;250:H645–H653.PubMedGoogle Scholar
  15. 15.
    Chilian WM, Ackell PH: Transmural differences in sympathetic coronary constriction during exercise in the presence of coronary stenosis. Circ Res 1988;62:216–225.PubMedCrossRefGoogle Scholar
  16. 16.
    Gwirtz PA, Stone HL: Coronary blood flow changes following activation of adrenergic receptors in the conscious dog. Am J Physiol 1982;243:H13–H19.PubMedGoogle Scholar
  17. 17.
    Heusch G: Control of coronary vasomotor tone in ischemic myocardium by local metabolism and neurohumoral mechanisms. Eur Heart J 1991;12:F99–F106.CrossRefGoogle Scholar
  18. 18.
    Heusch G: Alpha-adrenergic mechanisms in myocardial ischemia. Circulation 1990;81:1–13.PubMedCrossRefGoogle Scholar
  19. 19.
    Raizner AE, Chahine RA, Ishimori T, Verani MS, Zacca N, Jamal N, Miller RR, Luchi RJ: Provocation of coronary artery spasm by the cold pressor test. Circulation 1980;62:925–932.PubMedCrossRefGoogle Scholar
  20. 20.
    Brown BG, Bolson EL, Dodge HT: Dynamic mechanisms in human coronary artery stenosis. Circulation 1984;70:917–922.PubMedCrossRefGoogle Scholar
  21. 21.
    Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, Kilbom KM, Barger AC, Shannon DC, Cohen RJ, Benson H: Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151–H153.PubMedGoogle Scholar
  22. 22.
    Rosano GMC, Kaski JC: Abnormal neurohumoral control in the pathogenesis of syndrome X, in Kaski JC (ed): Angina pectoris with normal coronary arteries: Syndrome X. Boston, Kluwer Academic Publishers, 1994, pp 211–224.CrossRefGoogle Scholar
  23. 23.
    Rosano GMC, Ponikowski P, Adamopoulos S, Collins P, Poole-Wilson PA, Coats A, Kaski JC. Abnormal autonomic control of the cardiovascular system in syndrome X. Am.J.Cardiol. 73:1174–1179, 1994.CrossRefGoogle Scholar
  24. 24.
    Ponikowski P, Rosano GMC, Amadi A, Collins P et al. Transient autonomic dysfunction precedes ST-segment depression in patients with syndrome X. Am J Cardiol 1996; 77:942–947.PubMedCrossRefGoogle Scholar
  25. 25.
    Rosen SD, Dritsas A, Bourdillon PJ, Camici PG. Analysis of the electrocardiographic QT interval in patients with syndrome X. Am J Cardiol 1994; 73:971–972.PubMedCrossRefGoogle Scholar
  26. 26.
    Mammana C, Salomon O, Kautzner J, Schwartzman R, Kaski JC. Heart rate-independent prolongation of QTc interval in women with syndrome X. Clin Cardiol 1997; 20:357–360.PubMedCrossRefGoogle Scholar
  27. 27.
    Leonardo F, Fragasso G, Rosano GMC, Pagnotta P, Chierchia SL. Effect of atenolol on QT interval and dispersion in patients with syndrome X. Am J Cardiol 1997; 80: 789–90.PubMedCrossRefGoogle Scholar
  28. 28.
    Bassenge E, Walter P, Doutheil U: Wirkungsumkehr der adrenergischen coronargefassreaction in abhangigkeit vom coronargefasstonus. Pflugers Arch 1969;297:146–155.CrossRefGoogle Scholar
  29. 29.
    Maseri A, Crea F, Kaski JC, Crake T: Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991;17:499–506.PubMedCrossRefGoogle Scholar
  30. 30.
    Bortone AS, Hess OM, Eberli FR, Nonogi H, Marolf AP, Grimm J, Krayenbuehl HP. Abnormal coronary vasomotion during exercise in patients with normal coronary arteries and reduced coronary flow reserve. Circulation 79:516–527, 1989.PubMedCrossRefGoogle Scholar
  31. 31.
    Montorsi P, Cozzi S, Loaldi A, Fabbiocchi F, Polese A, de Cesare N, Guazzi MD: Acute coronary vasomotor effects of nifedipine and therapeutic correlates in syndrome X. Am J Cardiol 1990;66:302–307.CrossRefGoogle Scholar
  32. 32.
    Clarke J, Benjamin N, Larkin S, Webb D, Maseri A, Davies G: Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man. Circulation 1991;83:774–777.PubMedCrossRefGoogle Scholar
  33. 33.
    Kaski JC, Tousoulis D, Rosano GMC, Clarke J, McFadden E, Davies GJ: Role of Neuropeptide Y in the pathogenesis of syndrome X. Circulation 1992;86, No 4:I527.Google Scholar
  34. 34.
    Cannon RO, Schenke WH, Leon MB, Rosing DR, Urghart J, Epstein SE: Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. Circulation 1987;75:163–174.PubMedCrossRefGoogle Scholar
  35. 35.
    Kaski JC, Tousoulis D, Galassi AR, McFadden E, Pereira WI, Crea F, Maseri A: Epicardial coronary artery tone and reactivity in patients with normal coronary arteriograms and reduced coronary flow reserve (syndrome X). J Am Coll Cardiol 1991;18:50–54.PubMedCrossRefGoogle Scholar
  36. 36.
    Rosano GMC, Collins P, Kaski JC, Lindsay D, Sarrel PM, Poole-Wilson PA. Syndrome X is associated with oestrogen deficiency. Eur Heart J 1995; 16: 610–614.PubMedGoogle Scholar
  37. 37.
    Rees MC, Barlow DH: Absence of sustained reflex vasoconstriction in women with menopausal flushes. Hum Reprod 1988;3:823–825.PubMedGoogle Scholar
  38. 38.
    Rosano GMC, Peters N, Lefroy D, Lindsay D, Sarrel PM, Collins P, Poole-Wilson PA. 17-beta estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996; 28: 1500–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Kronenberg F, Cote LJ, Linkie DM, Dyrenfurth I, Downey JA: Menopausal hot flushes: thermoregulatory, cardiovascular and circulating catecholamine and LH changes. Maturitas 1984;6:3143.CrossRefGoogle Scholar
  40. 40.
    Fragasso G, Chierchia S, Pizzetti G, Rossetti E, Carlino M, Gerosa S, Carandente O, Fedele A, Cattaneo N: Impaired left ventricular filling dynamics in patients with angina pectoris and angiographically normal coronary arteries; effect of beta-adrenergic blockade. Heart 1997; 77: 32–39.PubMedGoogle Scholar
  41. 41.
    Fragasso G, Chierchia SL, Rossetti E, Landoni C, Lucignani G, Fazio F. Abnormal myocardial glucose handling in patients with syndrome X: effect of beta adrenergic blockade. Giorn It Cardiol 1997; 27: 1113–1120.Google Scholar
  42. 42.
    Rossetti E, Fragasso G, Vanzulli A et al. Magnetic resonance imaging in patients with angina and normal coronary angiograms. J Am Coll Cardiol 1994; 445A.Google Scholar
  43. 43.
    Newsholme EA, Start C. Regulation in metabolism. London: J Wiley and Sons, 1974: 329–37.Google Scholar
  44. 44.
    Van Zweiten PA. Interaction between alpha-and beta-adrenoceptor-mediated cardiovascular effects. J Cardiovasc Pharmacol 1986; 8 (4): S21–8.CrossRefGoogle Scholar
  45. 45.
    Jackson G, Atkinson L, Oram S. Improvement of myocardial metabolism in coronary artery disease by beta-blockade. Br Heart J 1977; 39: 829–33.PubMedCrossRefGoogle Scholar
  46. 46.
    Dean JD, Jones CJ, Hutchison SJ, Peters JR, Henderson AH: Hyperinsulinaemia and microvascular angina (“syndrome X”). Lancet 1991;337:456–457.PubMedCrossRefGoogle Scholar
  47. 47.
    Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 1993; 21: 88693.CrossRefGoogle Scholar
  48. 48.
    Deibert DC, De Fronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 1980; 65: 717–21.PubMedCrossRefGoogle Scholar
  49. 49.
    De Tejada IS, Goldstein I, Azadzio K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025–30.CrossRefGoogle Scholar
  50. 50.
    Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Pfeide B, Ditschuneit H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 1981; 20: 155–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Giuseppe M. C. Rosano
  • Gabriele Fragasso
  • Sergio L. Chierchia

There are no affiliations available

Personalised recommendations